Compare +50 FDA IDE Providers
When your team is planning a U.S. clinical investigation for a device, provider selection has a direct effect on timeline, quality, and cost. This directory is built for sponsors that need practical support under the FDA Investigational Device Exemption (IDE) framework, with clear comparison criteria and direct links to calculation tools for planning.
Build Your IDE Plan First, Then Choose a Provider
Use these tools before signing any scope of work so you can compare bids on the same assumptions.
Who This Directory Is For
This page is designed for U.S. and international medical device teams that plan to conduct a clinical investigation in the United States and need support with regulatory strategy, protocol and statistical planning, monitoring, data operations, submission publishing, and agency interaction prep. Most teams use a mix of internal regulatory ownership and external specialist providers.
The objective is not to outsource critical decisions blindly. The objective is to compare providers against your actual risk profile and development constraints. That means your shortlist should be based on your device class, stage of verification, expected risk profile, enrollment complexity, and whether your quality system is trial-ready for design control, complaint handling, and adverse event workflows.
How To Compare IDE Providers Without Overbuying
Many sponsors buy broad packages that include deliverables they do not need in phase one. A stronger approach is to map each service line to one of three outcomes: required for IDE acceptance, required for enrollment velocity, or optional optimization. If a provider cannot separate those buckets, that is usually an indicator of low transparency in scope and resourcing.
Shortlist Criteria That Matter
- Has the provider led IDE submissions for similar indications and risk levels?
- Can they show a realistic submission-to-feedback timeline, not a marketing timeline?
- Do they define assumptions for biostatistics and enrollment feasibility explicitly?
- Will they support agency interactions, including meeting prep and response drafting?
- Do they publish a change-control method for scope and budget updates?
- Can they work with your internal quality and document controls instead of replacing them?
Provider Categories You Will Usually Evaluate
Regulatory Strategy Specialists
Focus on IDE pathway, submission framing, and FDA interaction plans.
Clinical Operations CRO Teams
Manage sites, monitoring, enrollment tracking, and study execution.
Biostatistics & Data Providers
Support endpoint logic, statistical analysis plans, and data quality oversight.
Medical Writing & Publishing
Prepare protocol narratives, submission modules, and response packages.
Use These Calculators Before Finalizing Vendor Scope
- FDA IDE Readiness Calculator to identify pre-submission gaps.
- FDA IDE Clinical Study Timeline Calculator to model milestones and lag risk.
- FDA IDE Budget Calculator to compare scope-based provider bids.
Primary Sources Used For This Directory Framework
- 21 CFR Part 812 — Investigational Device Exemptions (eCFR)
- FDA IDE Overview
- FDA Guidance on IDE Need Determination
- CDRH Device Advice on IDE
Ready To Compare +50 FDA IDE Providers With A Real Baseline?
Start with readiness and budget assumptions, then evaluate vendors against the same measurable plan.
Start With the IDE Readiness Calculator